NPAT for H1 CY2019 was ~$41m. Now the second half of the year might only be about $10m NPAT due to the skewed earnings profile. So that would be ~ $50m in NPAT for the 2019 calendar year.
If we came in at $50m NPAT for 2019 CY, for a market cap of $1 billion ($3.20) that is a PE ratio of 20. For a PE ratio of 20 to be fair value (at a PEG ratio of 1), we would want to see earnings growing by 20% in CY20....
Thus, if you don't think earnings will grow by 20% or more in CY20, than this still looks overvalued on current performance.
Add to My Watchlist
What is My Watchlist?